LogiPharma Europe

Axway is at the forefront of technological innovations around track and trace technology and will discuss how its technology can be leveraged globally to protect companies and comply with the new coming regulations.

With the World Health Organization estimating that up to one percent of medicines available in the developed world are likely counterfeit, rising to more than 30 percent in large countries and 10 percent globally, there is a clear need for the industry to work together to address the huge risks posed by counterfeit drugs. In this context countries and regions of the world are enforcing regulations to the industry and primarily the manufacturers. As a result, Manufacturers become liable to patient safety and  they need to implement solutions to cope with these evolving regulations whilst maintaining their agility on their markets. Based on our return of experience, the session, titled “Drug anti-counterfeiting and regulation reporting!” will focus on the challenges and the practical impacts on the Information Systems from a manufacturer perspective.

The LogiPharma Europe is being held on April 24-26, 2012 at Hotel President Wilson, Geneva, Switzerland. The conference is an opportunity to discuss the latest developments and regulations in pharmaceutical serialization at an international level with leading experts from around the world.